Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

Edwards Lifesciences Price Quote

$66.85
+0.04 (+1.26%)
(Updated: September 7, 2024 at 6:32 AM ET)

Edwards Lifesciences Key Stats

Sell
16
Edwards Lifesciences (EW) is a Sell

Day range:
$65.47 - $67.04
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
29.05
P/S ratio:
6.75
P/B ratio:
5.41%

Volume:
5.9M
Avg. volume:
6.5M
1-year change:
-13.19%
Market cap:
$40.2B
Revenue:
$6B
EPS:
$2.43

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.22%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $866.1M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$591.4M
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $291M

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 19.6%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 15.48%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 21.3%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

  • Who Are Edwards Lifesciences's Competitors?
    Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
    • Becton Dickinson & Co (BDX)
    • Boston Scientific Corp (BSX)
    • NeuroOne Medical Technologies Corp (NMTC)
    • Nutriband Inc (NTRB)
    • SINTX Technologies Inc (SINT)

Edwards Lifesciences Dividend Yield

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: 22% 0.88%
Revenue: 6.98% -1.26%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 16
Sell Recommendations: 0
Price Target: 81.12
Upside from Last Price: 21.42%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    711.3M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.8M EW shares are owned by insiders